Induced Pluripotent Stem Cells and CRISPR-Cas9 Gene-Editing on Transthyretin Amyloid Cardiomyopathy. Global Journal of Science Frontier Research, [S. l.], v. 24, n. G1, p. 1–3, 2024. DOI: 10.34257/GJSFRGVOL24IS1PG1. Disponível em: https://testing.journalofscience.org/index.php/GJSFR/article/view/102918. Acesso em: 4 feb. 2026.